{
  "id": 2020,
  "text": "8 months.Dodd et al.1801 found elevated SCC-Ag levels before the clinical evidence of recurrence in $5 0 \\%$ of patients and at the time of recurrence in $2 5 \\%$ of patients with fatal squamous cell cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 8 months.Dodd et al.1801 found elevated SCC-Ag levels before the clinical evidence of recurrence in $5 0 \\%$ of patients and at the time of recurrence in $2 5 \\%$ of patients with fatal squamous cell cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌患者中，恶性鳞状上皮细胞癌抗原（SCC-Ag）水平可能在临床复发的证据出现之前就有所升高。在某些情况下，约50%的患者在临床复发前即出现SCC-Ag水平升高。在宫颈癌复发时，这些抗原水平会继续呈现变化，约25%的患者在复发时经历更显著的SCC-Ag水平升高。这表明SCC-Ag水平的变化可以作为宫颈癌复发的一个重要监测指标。通过密切监测SCC-Ag水平的变化，可以为宫颈癌复发提供早期预警，并指导临床决策。",
  "query": "患者在宫颈癌复发前，恶性鳞状上皮细胞癌抗原（SCC-Ag）水平升高发生在哪些情况下，以及在复发时这些水平的变化情况如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 患者在宫颈癌复发前，恶性鳞状上皮细胞癌抗原（SCC-Ag）水平升高发生在哪些情况下，以及在复发时这些水平的变化情况如何？\n\n<reference text>: 8 months.Dodd et al.1801 found elevated SCC-Ag levels before the clinical evidence of recurrence in $5 0 \\%$ of patients and at the time of recurrence in $2 5 \\%$ of patients with fatal squamous cell cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌患者中，恶性鳞状上皮细胞癌抗原（SCC-Ag）水平可能在临床复发的证据出现之前就有所升高。在某些情况下，约50%的患者在临床复发前即出现SCC-Ag水平升高。在宫颈癌复发时，这些抗原水平会继续呈现变化，约25%的患者在复发时经历更显著的SCC-Ag水平升高。这表明SCC-Ag水平的变化可以作为宫颈癌复发的一个重要监测指标。通过密切监测SCC-Ag水平的变化，可以为宫颈癌复发提供早期预警，并指导临床决策。"
}